Dudediligence.

ANI Pharmaceuticals, Inc

ANIPNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

22.5M

on 2025-12-31, from 21.1M on 2024-12-31 10-K ↗

a raise that quarter, at its price

5M10M15M20MDec2024Dec2025

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

3 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-07 is not read yet.

Cash

$360.2M

Operating cash flow was positive over the four quarters to 2026-06-30, so no quarters are counted. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2025-09-26Private placementnot readnot read$25.0M8-K ↗